Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma clinical trials

Explore recruiting locally advanced unresectable esophageal squamous cell carcinoma clinical trials.

Recruiting locally advanced unresectable esophageal squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center, International Study of Durvalumab Given Concurrently With Definitive Chemoradiation Therapy in Patients With Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma (KUNLUN).

Spain, France, Belgium, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma trials by city

Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Toronto Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Vancouver Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Montreal Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Calgary Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Edmonton Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Ottawa Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Winnipeg Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Quebec City Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Hamilton Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Kitchener Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in London Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Halifax Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in New York Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Los Angeles Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Chicago Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease